Nathan Stasko Selected Research

Vaccines

1/2022

Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan Stasko Research Topics

Disease

4	COVID-19 01/2022 - 01/2022
1	Infections 01/2022
1	Skin Diseases (Skin Disease) 10/2018
1	Warts (Wart) 10/2018
1	Tinea Pedis (Athlete's Foot) 08/2018
1	Onychomycosis (Tinea Unguium) 01/2018
1	Mycoses (Diseases, Fungus) 01/2018
1	Acne Vulgaris 08/2016

Drug/Important Bio-Agent (IBA)

4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 08/2016
2	berdazimer sodiumIBA 10/2018 - 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Artificial SalivaIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	AntigensIBA 01/2022
1	VaccinesIBA 01/2022
1	HydrogelsIBA 10/2018
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2018
1	Investigational DrugsIBA 10/2018
1	Siloxanes (Siloxane)IBA 01/2018

Therapy/Procedure

1	Phototherapy (Light Therapy) 01/2022
1	Therapeutics 01/2018